Translate

Tuesday, January 16, 2018

thumbnail

CBIO Catalyst Biosciences, Inc. gains 195% Jan 16, 2018

Targacept, Inc., a biopharmaceutical company, engages in the development of neuronal nicotinic receptors (NNR) therapeutics for the treatment of nervous system and gastrointestinal/genitourinary diseases and disorders. http://www.priceseries.com/trade/CBIO-Catalyst-Biosciences-Inc--stock-gains-195-percent-a-Trade-Record-by-priceSeries-2017111520180116.html

Subscribe by Email

Follow Updates Articles from This Blog via Email

No Comments

TradeVisor Product Review

Review I II III IV

Blog Archive